Developing science,
delivering therapies
Our company
We are pioneers in harnessing bacteria as a revolutionary new class of medicines β called live biotherapeutics.
Our approachDeveloping science
From asthma to cancer, we conduct world-leading research to identify live biotherapeutics with drug-like functionality to treat a range of diseases.
What we doDelivering therapies
We are uniquely positioned to rapidly translate our research into regulated, safe and efficacious therapies for patients.
Find out moreNews
4D pharma plc announces merger with Longevity, a special purpose acquisition company (SPAC), and its intention to gain a NASDAQ listing
4D pharma announces topline results from Blautix® Phase II BHT-II-002 trial in IBS-C and IBS-D
BACK TO TOP